Bruno Chaves: Ibogaine in Brazil - Finally Stepping Out from the Underground?

Ibogaine treatment in Brazil remains a restricted, though not explicitly forbidden, medical practice. Because the substance is not a registered medicine, its usage is currently managed through legal importation for individual patient use under strict, physician-supervised clinical oversight. Regulations governing the importation of unregistered medicines allow for this practice as a necessary pathway for treatment, though complex logistics currently drive up costs for patients. Integration into standard medical practice faces significant bureaucratic hurdles, particularly regarding the high cost of formal drug registration. Despite these challenges, proponents are engaging with government health authorities to formalize safe administration protocols and secure funding for further clinical research. The aim is to transition from a specialized, individual-based importation model to broader therapeutic access under controlled, hospital-based medical guidelines.